Loading...
Loading...
TG Therapeutics, Inc. TGTX was a big mover last session, as the company saw its shares surge nearly 13% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $5.35 to $9.61 in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday's price action is encouraging, so make sure to keep a close watch on this firm in the near future.
TG Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other better-ranked players in the same industry include Cardica Inc. CRDC, NeuroMetrix Inc. NURO and ICU Medical, Inc. ICUI all carrying a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free reportTG THERAPEUTICS TGTX: Free Stock Analysis Report
CARDICA INC CRDC: Free Stock Analysis Report
NEUROMETRIX INC NURO: Get Free Report
ICU MEDICAL INC ICUI: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in